Criteria for Prescribing Dabigatrin Etexilate and Rivaroxaban Really Appropriate? Comment

Abstract

Get full access to this article

View all access options for this article.

References

Larock

Mullier

Sennesael

. Appropriateness of prescribing dabigatranetexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective study. Ann Pharmacother. 2014;48:1258-1268. doi:10.1177/10600280-14540868.

Camm

Lip

De Caterina

. 2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719-2747. doi:10.1093/eurheartj/ehs253.

January

Wann

Alpert

. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardio-logy/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [published online March 28, 2014]. J Am Coll Cardiol. doi:10.1016/j.jacc.2014.03.022.

Connolly

Ezekowitz

Yusuf

. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151. doi:10.1056/NEJMoa0905561.

Patel

Mahaffey

Garg

. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891. doi:10.1056/NEJMoa1009638.